Hypertrophic cardiomyopathy in a Mexican female with Fabry disease: challenges in multidisciplinary diagnosis. family with novel pathogenic GLA gene variants.

31 August 2025 (14:30 - 14:42)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Jesus Alberto Garcia Diaz

Regional Hospital Dr. Valentin Gomez Farias, Zapopan (Mexico)

4 More presentations in this session

Presentation thumbnail

Morgagni-Adam-Stokes syndrome as first manifestation of Anderson-Fabry disease

Doctor G. Marchionni (Rome, IT)

Presentation thumbnail

Utilising mavacamten to mitigate post TAVR suicide left ventricle risk in patient with concomitant severe aortic stenosis, hypertrophic obstructive cardiomyopathy, and severe coronary artery disease.

Doctor C. Mew (Brisbane, AU)

Presentation thumbnail

Red flags plays a significant role in the diagnosis of Anderson–Fabry disease

Miss A. Yang (Hangzhou, CN)

Presentation thumbnail

Connecting the dots in a young patient with left ventricular hypertrophy, diabetes and deafness

Doctor A. Papageorgiou (Athens, GR)

Access the full session

Session thumbnail

Hypertrophic cardiomyopathy: challenges in diagnosis and treatments

The Event

Event poster

ESC Congress 2025

31 August 2025 14:30 CET

You may be interested in

Congress Presentation

Identification of a pathogenic variant in the GLA gene in a patient with a hypertrophic phenotype: can hypertrophic cardiomyopathy be excluded?

Congress Session

Hypertrophic cardiomyopathy: challenges in diagnosis and treatments

Congress Session

When one diagnosis is not enough: overlap cardiomyopathies and genetic clues

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources